Molecular mechanisms underlying the tetrandrine-mediated reversal of the fluconazole resistance of Candida albicans

Pharmaceutical Biology

Volumn 51, Issue 6, 2013, Pages 749-752

  Zhang, Xiaoli ^a   Guo, Hui ^a   Gao, Laiqiang ^a   Song, Yanjun ^a   Li, Shuixiu ^a   Zhang, Hong ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

ADH1; Candida albicans; Fluconazole; Real time RT PCR; Resistance; Reverse; Tetrandrine

Indexed keywords

ADENOSINE TRIPHOSPHATE; FLUCONAZOLE; TETRANDRINE;

ADH1 GENE; ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA ALBICANS; CDR1 GENE; CDR2 GENE; CELL LEVEL; CONTROLLED STUDY; DRUG STRUCTURE; ENERGY METABOLISM; ERG11 GENE; FLU1 GENE; FUNGAL GENE; FUNGAL STRAIN; GENE EXPRESSION REGULATION; GENE FUNCTION; MDR1 GENE; NONHUMAN;

ADENOSINE TRIPHOSPHATE; ALCOHOL DEHYDROGENASE; ANTIFUNGAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BENZYLISOQUINOLINES; CANDIDA ALBICANS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; FUNGAL PROTEINS; GENE EXPRESSION REGULATION; MEMBRANE TRANSPORT PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84877830532     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2013.764537     Document Type: Article

References (20)

1. Alangaden GJ. (2011). Nosocomial fungal infections: Epidemiology, infection control, and prevention. Infect Dis Clin North Am 25:201-25.
2. Bertram G, Swoboda RK, Gooday GW, et al. (1996). Structure and regulation of the Candida albicans ADH1 gene encoding an immunogenic alcohol dehydrogenase. Yeast 12:115-27. (Pubitemid 26059932)
3. Bulatova NR, Darwish RM. (2008). Effect of chemosensitizers on minimum inhibitory concentrations of fluconazole in Candida albicans. Med Princ Pract 17:117-21. (Pubitemid 351301296)
4. Chen L, Li QY, Yang Y, et al. (2009). Inhibitory effects of tetrandrine on the Na(+) channel of human atrial fibrillation myocardium. Acta Pharmacol Sin 30:166-74.
5. Craver CW, Tarallo M, Roberts CS, et al. (2010). Cost and resource utilization associated with fluconazole as first-line therapy for invasive candidiasis: A retrospective database analysis. Clin Ther 32:2467-77.
6. Fu Z, Lu H, Zhu Z, et al. (2011). Combination of baicalein and amphotericin B accelerates Candida albicans apoptosis. Biol Pharm Bull 34:214-18.
7. Goldman GH, da Silva Ferreira ME, dos Reis Marques E, et al. (2004). Evaluation of fluconazole resistance mechanisms in candida albicans clinical isolates from HIV-infected patients in Brazil. Diagn Microbiol Infect Dis 50:25-32. (Pubitemid 39360259)
8. Henry KW, Nickels JT, Edlind TD. (2000). Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors. Antimicrob Agents Chemother 44:2693-700.
9. Huang P, Xu Y, Wei R, et al. (2011). Efficacy of tetrandrine on lowering intraocular pressure in animal model with ocular hypertension. J Glaucoma 20:183-8.
10. Marchetti O, Moreillon P, Entenza JM, et al. (2003). Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes. Antimicrob Agents Chemother 47:1565-70. (Pubitemid 36548538)
11. Pfaller MA. (2012). Antifungal drug resistance: Mechanisms, epidemiology, and consequences for treatment. Am J Med 125:S3-13.
12. Shi J, Zhang H, Zhang Z, et al. (2011). Synergistic effects of tetrandrine on the antifungal activity of topical ketoconazole cream in the treatment of dermatophytoses: A clinical trial. Chin J Integr Med 17:499-504.
13. Shukla S, Rai V, Saini P, et al. (2007). Candida drug resistance protein 1, a major multidrug ATP binding cassette transporter of Candida albicans, translocates fluorescent phospholipids in a reconstituted system. Biochem 46:12081-90. (Pubitemid 350022364)
14. Sun S, Li Y, Guo Q, et al. (2008). In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methods. Antimicrob Agents Chemother 52:409-17. (Pubitemid 351170807)
15. Tsao S, Rahkhoodaee F, Raymond M. (2009). Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance. Antimicrob Agents Chemother 53:1344-52.
16. Wang Z, Zhang G, Zhang X, et al. (2012). Proteomic analysis of fluconazole resistance in Candida albicans. Afr J Pharm Pharmaco 6:1226-30.
17. White TC, Holleman S, Dy F, et al. (2002). Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother 46:1704-13. (Pubitemid 34535186)
18. Yan L, Zhang J, Li M, et al. (2008). DNA microarray analysis of fluconazole resistance in a laboratory Candida albicans strain. Acta Biochim Biophys Sin (Shanghai) 40:1048-60.
19. Zhang H, Gao A, Li F, et al. (2009). Mechanism of action of tetrandrine, a natural inhibitor of Candida albicans drug efflux pumps. Yakugaku Za 129:623-30.
20. Zhang H, Wang K, Zhang G, et al. (2010). Synergistic anti-candidal activity of tetrandrine on ketoconazole: An experimental study. Planta Med 76:53-61.